Germany’s Bayer and privately-held Kumquat Biosciences, a US biotech founded by pioneers of the KRAS pathway, have entered into an exclusive global license and collaboration to develop and ...

US pharma giant Pfizer and Japan’s Astellas Pharma today announced positive top-line results from the Phase III EV-303 ...

US generics major Viatris has won US Food and Drug Administration (FDA) approval for iron sucrose injection, USP, an ...

US pharma major Eli Lilly (NYSE: LLY) is partnering with the UK’s Department for Science, Innovation and Technology to fund ...

US biotech Rezo Therapeutics today announced the appointment of Derek Hicks as its chief executive (CEO). With more than 25 ...

USA-based Bionova Scientific, a full-service contract development and manufacturing organization (CDMO) for biologics and a subsidiary of Japanese technology company Asahi Kasei, has announced the ...

UK and USA-listed PureTech Health today announced the launch of a new founded entity to be called Celea Therapeutics.

South Korea is fast becoming a focal point for global biopharmaceutical licensing, with deal values reaching $7.86 billion ...

Eli Lilly has announced positive top-line results from the Phase III BRUIN CLL-314 trial of Jaypirca (pirtobrutinib), a ...

The pharmaceutical industry is on high alert as US President Donald Trump proposes a 200%-250% tariff on drug imports, which ...

The US Food and Drug Administration (FDA) has announced the fiscal year 2024 Report on the State of Pharmaceutical Quality ...

Sweden’s Enzymatica has appointed Sana Alajmovic as its new chief executive (CEO), succeeding Claus Egstrand, who has ...